JPMorgan Chase & Co. Analysts Give AXA (CS) a €29.20 Price Target
AXA (EPA:CS) has been assigned a €29.20 ($36.05) price target by equities research analysts at JPMorgan Chase & Co. in a research note issued to investors on Tuesday. The firm presently has a “buy” rating on the stock. JPMorgan Chase & Co.’s price target indicates a potential upside of 10.19% from the stock’s previous close.
A number of other brokerages also recently weighed in on CS. UBS Group set a €26.00 ($32.10) price objective on shares of AXA and gave the stock a “neutral” rating in a research report on Tuesday, January 16th. Kepler Capital Markets set a €29.80 ($36.79) price objective on shares of AXA and gave the stock a “buy” rating in a research report on Friday, November 3rd. Baader Bank set a €27.00 ($33.33) price objective on shares of AXA and gave the stock a “buy” rating in a research report on Friday, November 3rd. Royal Bank of Canada set a €29.00 ($35.80) price objective on shares of AXA and gave the stock a “buy” rating in a research report on Tuesday, January 16th. Finally, Citigroup reiterated a “neutral” rating on shares of AXA in a research report on Tuesday, November 14th. Four equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of €28.14 ($34.74).
AXA (EPA:CS) opened at €26.50 ($32.72) on Tuesday. The firm has a market cap of $64,260.00 and a PE ratio of 11.28. AXA has a 1 year low of €21.81 ($26.93) and a 1 year high of €27.69 ($34.19).
AXA SA (AXA) is a France-based holding company engaged in the business of financial protection. The Company’s segments include Life & Savings, Property & Casualty, Asset Management , Banking and Holding companies. The Life & Savings segment’s products include a range of investment and savings products, as well as Protection and Health products.
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.